Novo Nordisk plummeted 21.6%, and the Danish pharmaceutical giant lowered sales and profit expectations for the full year. Whirlpool plummeted 12.9%, and the home appliance company's Q2 results fell short of expectations. Biotech company Sarepta Therapeutics rose 35.7%, and the company was approved by the FDA for restorative gene therapy Elevidys for the treatment of Duchenne muscular dystrophy. Daxin Energy rose 4.7%, and the photovoltaic industry ushered in a paradigm shift in sentiment. Xiaomo is optimistic.

Novo Nordisk plummeted 21.6%, and the Danish pharmaceutical giant lowered sales and profit expectations for the full year. Whirlpool plummeted 12.9%, and the home appliance company's Q2 results fell short of expectations. Biotech company Sarepta Therapeutics rose 35.7%, and the company was approved by the FDA for restorative gene therapy Elevidys for the treatment of Duchenne muscular dystrophy. Daxin Energy rose 4.7%, and the photovoltaic industry ushered in a paradigm shift in sentiment. Xiaomo is optimistic.